活動議程

DATE: July 13-14, 2026
VENUE: National Biotechnology Research Park (NBRP), Taipei, Taiwan
THEME: Science to Impact - Powered by Innovation and Resources
AGENDA
DAY 1 (July 13)
Target Participants: Biopharmaceutical Industry • Startups • Incubated Companies
Time Program Concurrent Activities
09:00-10:00 Registration Company Exhibition

Poster Showcase
10:00-10:15 Opening Remarks
Chien-Jen Chen, President, Academia Sinica
Chien-Chang Chen, Director, Biomedical Translation Research Center (BioTReC), Academia Sinica
Tsai-Kun Li, President, Development Center for Biotechnology (DCB)
10:15-10:25 Guest Remarks
Ting-An Wang, Executive Secretary, National Development Fund, Executive Yuan
Chih-Kang Chiang, Director General, Taiwan Food and Drug Administration (TFDA)
10:25-10:30 Group Photo
10:30-11:10 Keynote Address
Rudi Pauwels, Founder & President, Praesens Foundation
Moderator: Tsai-Kun Li, President, DCB
11:10-11:15 Coffee Break
11:15-12:00 Executive Forum
Reshaping Taiwan's Biotech Ecosystem: Driving Industry Globalization

Panelists:
Rudi Pauwels, Founder & President, Praesens Foundation
Yiu-Lian Fong, Founder & Owner, DxRxPM Biotech Consulting
Hiroki Narita, President & CEO, DCI Partners
Michael Huang, Managing Partner of Bio Fund, Taiwania Capital
Harvey Chin, Head of Global Strategy, PharmaEssentia
Moderator: Michael Huang, VP, DCB
12:00-13:00 Networking Lunch
13:00-13:30 Therapeutics Pitch One-on-One Partnering
13:30-13:50 Therapeutics Q&A
13:50-14:10 Networking & Coffee Break
14:10-14:40 Medical Device Pitch
14:40-15:00 Medical Device Q&A
15:00-15:20 Networking & Coffee Break
15:20-15:55 Australian Innovation Showcase
15:55-16:10 Australian Showcase Q&A
16:10-16:40 Awards Ceremony
DAY 2 (July 14)
Target Participants: Translational Teams • Academia • Healthcare Organizations
Time Program Concurrent Activities
09:00-10:00 Registration Company Exhibition

Poster Showcase
10:00-10:35 Keynote Address
Matthew Porteus, M.D., Ph.D., Director, Center for Definitive and Curative Medicine (CDCM), Stanford University
Moderator: Alice Lin-Tsing Yu, Academician, Academia Sinica
10:35-11:10 Executive Forum
Early-Stage Translational Practices: Building an Express Strategy from Lab to First-in-Human

Panelists:
Matthew Porteus, M.D., Ph.D., Director, Center for Definitive and Curative Medicine (CDCM), Stanford University
Yun Yen, Chair Professor & Emeritus President, Taipei Medical University
Alice Lin-Tsing Yu, Academician, Academia Sinica
Kotaro Funato, Partner, Health Industries Advisory, PwC Japan
Ryan Potts, VP, Induced Proximity Platform, Amgen
Moderator: Chien-Chang Chen, Director, BioTReC
11:10-11:25 Networking & Coffee Break
11:25-11:45 Overview of Government Biomedical R&D Resources
Michael Huang, VP, DCB
11:45-12:00 Taiwan Contract Research One-Stop Service: Introduction to T.CROSS
Charlie Chen-En Cheng, Deputy Technical Director, National Center for Biomodels, NIAR
12:00-13:30 Networking Lunch
13:30-14:00 Therapeutics Pitch Resume Consultation
14:00-14:20 Therapeutics Q&A
14:20-14:40 Networking & Coffee Break
14:40-15:10 Medical Device Pitch
15:10-15:30 Medical Device Q&A
15:30-15:50 Networking & Coffee Break
15:50-16:20 Awards Ceremony